ShareValue scores for ORCHPHARMA.NSE: Valuation 45, Quality 32, Growth 35, Health 52.

ORCHPHARMA.NSE
NSE

Orchid Pharma Limited

₹997.55(+0.73%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

4% to 16%
Valuation
45
Fair Value
Price vs Value
Quality
32
Weak
Business Strength
Growth
35
Weak
Revenue & Earnings
Health
52
Moderate
Financial Stability
Momentum
93
Bullish
Price Trend

Company Details

About

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins; human and veterinary products; and antibiotics, including betalactam, macrolide, fluoroquinolone, and imidazole. The company also exports its products to approximately 40 countries internationally. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai, India. Orchid Pharma Limited operates as a subsidiary of Dhanuka Laboratories Limited.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026